Effects of Ginkgo biloba extracts on NMDA-activated currents in acutely isolated hippocampal neurons of the rat

Phytotherapy Research

Volumn 25, Issue 1, 2011, Pages 137-141

  Li, Shao ^a   Luo, Jie ^a   Wang, Xi ^a   Guan, Bing Cai ^b   Sun, Chang Kai ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Ginkgo biloba extracts; hippocampal neuron; N methyl d aspartate receptor; whole cell patch clamp

Indexed keywords

GINKGO BILOBA EXTRACT; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; COMPARATIVE STUDY; DRUG FORMULATION; DRUG MECHANISM; DRUG POTENCY; ELECTROPHYSIOLOGY; HIPPOCAMPUS; IC 50; NERVE CONDUCTION; NEUROPROTECTION; NONHUMAN; RAT;

ANIMALS; GINKGO BILOBA; HIPPOCAMPUS; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; PARTICLE SIZE; PATCH-CLAMP TECHNIQUES; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SOLUBILITY;

GINKGO BILOBA; RATTUS;

EID: 78650670313     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3235     Document Type: Article

References (21)

1. Ahlemeyer B, Krieglstein J., 2003. Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci 60: 1779-1792.
2. Bäurle P, Suter A, Wormstall H., 2009. Safety and effectiveness of a traditional ginkgo fresh plant extract-results from a clinical trial. Forsch Komplementmed 16: 156-161
3. Calcagnotto ME, Baraban SC., 2005. Prolonged NMDA-mediated responses, altered ifenprodil sensitivity, and epileptiform-like events in the malformed hippocampus of methylazoxymethanol exposed rats. J Neurophysiol 94: 153-162.
4. Chandrasekaran K, Mehrabian Z, Spinnewyn B, Chinopoulos C, Drieu K, Fiskum G., 2002. Bilobalide, a component of the Ginkgo biloba extract (EGb 761), protects against neuronal death in global brain ischemia and in glutamate-induced excitotoxicity. Cell Mol Biol (Noisy-le-grand) 48: 663-669.
5. Chandrasekaran K, Mehrabian Z, Spinnewyn B, Chinopoulos C, Drieu K, Fiskum G., 2003. Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death. Pharmacopsychiatry 36 (S1): 89-94.
6. Chandrasekaran K, Mehrabian Z, Spinnewyn B, Drieu K, Fiskum G., 2001. Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGB761) in gerbil global brain ischemia. Brain Res 922: 282-292.
7. Chandrasekaran K, Mehrabian Z, Spinnewyn B, Chinopoulos C, Drieu K, Fiskum G., 2003 Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death [J ]. Pharmacopsychiatry 36 (S1): 8994.
8. Chen L, Liu CJ, Tang M, et al,. 2006. Action of β-amyloid peptide1-40 on IHVA and its modulation by ginkgolide B. Sheng Li Xue Bao 58: 14-20.
9. Davies JA, Johns L, Jones FA., 2003. Effects of bilobalide on cerebral amino acid neurotransmission. Pharmacopsychiatry 36 (S1): S84-S88.
10. Izzo AA, Ernst E., 2009. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 69: 1777-1798.
11. Koch E., 2005. Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. Phytomedicine 12: 10-16.
12. Kreuter J., 1996. Nanoparticles and microparticles for drug and vaccine delivery. J Anat 189: 503-505. (Pubitemid 27011002)
13. Lipton SA., 2004. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx 1: 101-110.
14. Mechírová E, Domoráková I, Danková M, Danielisová V, Burda J., 2009. Effect of noradrenalin and EGb 761 pretreatment on the ischemia-reperfusion injured spinal cord neurons in rabbits. Cell Mol Neurobiol 29: 991-998.
15. Möddel G, Jacobson B, Ying Z, et al,. 2005. The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia. Brain Res 1046: 10-23.
16. Qi W, Ding D, Salvi RJ., 2008. Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures. Hear Res 236: 52-60.
17. Ryu KH, Han HY, Lee SY, et al,. 2009. Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time. Thromb Res 124: 328-334.
18. Saleem S, Zhuang H, Biswal S, Christen Y, Doré S., 2008. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 39: 3389-3396.
19. Taguchi R, Nishikawa H, Kume T, et al,. 2003. Serofendic acid prevents acute glutamate neurotoxicity in cultured cortical neurons. Eur J Pharmacol 477: 195-203.
20. Weichel O, Hilgert M, Chatterjee SS, Lehr M, Klein J., 1999. Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 360: 609-615.
21. Wang F, Zhao G, Cheng L, Zhou HY, Fu LY, Yao WX., 2004. Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus. Brain Res 999: 91-97. (Pubitemid 38121454)